Previous 10 | Next 10 |
2023-09-22 05:00:26 ET Worried that the Federal Reserve is driving our economy off a cliff? I’ve got two words for you: Drugs ‘n diapers . Actually, I forgot one. Dividends . These companies are about as recession-resistant as they come. Let’...
JADA Rapidly and Effectively Controlled Bleeding Due to PPH, 1 Reinforcing Pivotal Study Results 1 PPH is a Significant Cause of Maternal Morbidities in the U.S. 2,3,4,5 New Exploratory Post-Hoc Analysis Examined the Relationship Between Reported Severe Maternal Morbidity (SMM...
2023-09-10 02:23:12 ET Summary Organon & Co. stock is down 30% year-to-date and 40% below its 52-week highs. OGN offers a dividend yield of 5.8%, making it an attractive option for income-oriented investors. The company has a stable revenue base and potential for future di...
2023-09-09 07:20:00 ET On average, healthcare stocks haven't kept up with the gains made by the rest of the market this year. While the S&P 500 index is up by more than 17% year to date, that sector's stocks are down by nearly 3%. That trend, though, created some great opportunities...
Organon (NYSE: OGN), a global healthcare company with a focus on women’s health, today announced the appointment of Juan Camilo Arjona Ferreira, M.D., as Chief Medical Officer (CMO) and Charlotte Owens, M.D., as Head of Medical Affairs and Outcomes Research, strengthening the companyȁ...
VANCOUVER, BC / ACCESSWIRE / August 28, 2023 / (TSXV:OGN)(OTCQX:OGNRF) Orogen Royalties Inc. ("Orogen" or the "Company") is pleased to report profitable financial results from its operations for the second quarter ended June 30, 2023. Paddy Nicol, CEO of Orogen, commented: "We are happy to re...
2023-08-22 09:23:41 ET More on 3M: 3M Company: Small Beat, Weak Guidance. Story Still All About The Liabilities 3M Company: Soaring On Earnings 3M Company: I Replaced A Loser With These Three Leaders For further details see: 3M grabs Hanson from Zimmer Bi...
VANCOUVER, BC / ACCESSWIRE / August 16, 2023 / (TSXV:OGN)(OTCQX:OGNRF) Orogen Royalties Inc. ("Orogen") or the ("Company") is pleased to provide an update on its royalty portfolio and forecast for the second half of 2023. Paddy Nicol, CEO of Orogen, commented: "Our royalty portfolio consists of...
2023-08-10 11:01:31 ET Summary Organon & Co. posted its Q2 2023 earnings on 8th August. The Merck spinouts' 3 main divisions are Women's Health, Biosimilars, and Established Brands. Total revenues were $1.6bn - up 4% ex-FX fluctuations - and diluted EPS was $0.95 - both ou...
2023-08-08 14:47:06 ET Organon ( NYSE: OGN ) stock on Tuesday was among the top percentage gainers on the S&P 500 ( SP500 ), after the women's health company reported strong Q2 results on the back of increased sales of its contraceptive Nexplanon and growth in its biosi...
News, Short Squeeze, Breakout and More Instantly...
VANCOUVER, BC / ACCESSWIRE / July 24, 2024 / (TSXV:OGN)(OTCQX:OGNRF) Orogen Royalties Inc. ("Orogen" or the "Company") is pleased to announce updates for its partner funded exploration stage projects and royalties. Highlights Estimated 30,000 metres of drilling in seven planned or comp...
Company estimates $15 million of milestone expense in the second quarter Organon (NYSE: OGN), a global healthcare company with a focus on women’s health, will release its second quarter 2024 financial results on August 6, 2024, prior to the company’s webcast and conference...
2024-06-08 06:50:00 ET Not all dividend stocks are equal. Some are safer than others. Some have much higher dividend yields than others. When a stock offers both advantages, it's usually a keeper. Three Motley Fool contributors have found stocks with mouthwatering dividends that you...